enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Newly Published Data Indicates St. Jude Medical Trifecta ...

   www.aol.com/news/2013-03-19-newly-published-data...

   The Trifecta (TM) Valve. (Photo: St. Jude Medical, Inc.) Conducted at 31 medical centers in the U.S., Canada and Europe, the study followed 1,014 eligible patients implanted with the Trifecta ...

3. FDA: Recall of St. Jude Heart Surgery Device Is Most ... - AOL

   www.aol.com/2013/02/14/fda-recall-of-st-jude...

   The Food and Drug Administration has announced on its website that medical device maker St. Jude Medical last month recalled a device used in heart surgery because of the risk that it could cause ...

4. Artificial heart valve - Wikipedia

   en.wikipedia.org/wiki/Artificial_heart_valve

   An artificial heart valve is a one-way valve implanted into a person's heart to replace a heart valve that is not functioning properly (valvular heart disease).Artificial heart valves can be separated into three broad classes: mechanical heart valves, bioprosthetic tissue valves and engineered tissue valves.

5. These Are the 2 Biggest Signs of Heart Valve Damage ... - AOL

   www.aol.com/2-biggest-signs-heart-valve...

   Dr. Davis emphasizes that valve damage is not only caused by poor dietary habits, explaining, “Diet is often talked about in connection to heart disease, but valve damage has different causes.

6. St. Jude Medical - Wikipedia

   en.wikipedia.org/wiki/St._Jude_Medical

   St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.

7. Transcatheter aortic valve replacement - Wikipedia

   en.wikipedia.org/wiki/Transcatheter_aortic_valve...

   However, the risks associated with surgical aortic valve replacement are increased in elderly patients and those with concomitant severe systolic heart failure or coronary artery disease, as well as in people with comorbidities such as cerebrovascular and peripheral arterial disease, chronic kidney disease, and chronic respiratory dysfunction.